1-20 of 124
Dehui Zou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after BTK inhibitor era

Free
Weihao Chen, Yuting Yan, Ying Yu, Yuxi Li, Xiong Wenjie, Xinyi Zhang, Tingyu Wang, Wei LIU, Weiwei Sui, Zhen Yu, Mu Hao, Gang An, Dehui Zou, Lugui Qiu, Shuhua Yi
Journal: Blood
Blood (2025) 146 (Supplement 1): 3593.
https://doi.org/10.1182/blood-2025-3593
Published: 2025
Journal Articles

First-in-human trial of GT719, a novel stem cell-derived allogeneic anti-CD19 CAR-iNKT cell therapy for relapsed/refractory B cell malignancies

Free
Dehui Zou, Wei LIU, Yan Xu, Huimin Liu, Yi Wang, Sisi Feng, Xiaona Xu, He Zhang, Ershao Zhang, Jiang Li, Jingman Wang, Jing Hao, Ning Wang, Huiping Zheng, Yin Cheng, Jun Cui, Jingwei Sun, Yarong Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7693.
https://doi.org/10.1182/blood-2025-7693
Published: 2025
Journal Articles

Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study

Free
Zi-Xun Yan, Wenbin Qian, Ying Lu, Keshu Zhou, Dongmei Ji, Yuhua Li, Dehui Zou, Lanfang Li, Lei Zhang, Ping Li, Hongmei Jing, Chunyan Ji, Ting Niu, Fei Li, Xiaojian Zhu, Jinghua Zhao, Yu Hu, Depei Wu, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7230.
https://doi.org/10.1182/blood-2025-7230
Published: 2025
Journal Articles

Integration of longitudinal ctdna MRD and PET/CT enhances prognostic stratification in newly diagnosed diffuse large B-cell lymphoma: A prospective multicenter study

Free
Wei LIU, Fei Li, Keshu Zhou, Changming Dong, Zhiwei Chen, Xueli Jiao, Qianying Pan, Shunjin Zhang, Xiaoxia Wang, Xiao Liu, Dehui Zou, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5323.
https://doi.org/10.1182/blood-2025-5323
Published: 2025
Journal Articles

BCMA CAR T-cell therapy in newly diagnosed transplant-ineligible multiple myeloma: An open label, single-arm, phase 2 study (CAREMM-001)

Free
Wenqiang Yan, Chenxing Du, Hesong Zou, Shuaishuai Zhang, Shuhui Deng, Yan Xu, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 2293.
https://doi.org/10.1182/blood-2025-2293
Published: 2025
Journal Articles

Pola-R-edch shows high response rates in high-risk aggressive B-cell lymphomas or PMBCL: A phase 2 study

Free
Wei LIU, Yi Wang, Huimin Liu, Qi Wang, Hesong Zou, Yan Xu, Wenyang Huang, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 3683.
https://doi.org/10.1182/blood-2025-3683
Published: 2025
Journal Articles

Metabolomics profiling and machine learning prediction of efficacy and prolonged cytopenia in patients with large B-cell lymphoma undergoing CAR-T therapy

Free
Hesong Zou, Chen Jia, Wei LIU, Huimin Liu, Yi Wang, Yan Xu, Shuhua Yi, Gang An, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 1938.
https://doi.org/10.1182/blood-2025-1938
Published: 2025
Journal Articles

Preliminary analysis of orelabrutinib combined with obinutuzumab in the treatment of marginal zone lymphoma (Orion Study)

Free
Rui Lv, Tingyu Wang, Yuting Yan, Tengteng Yu, Xiong Wenjie, Ying Yu, Qi Wang, Shuaishuai Zhang, Hesong Zou, Shuhui Deng, Yan Xu, Dehui Zou, Liang Huang, Gang An, Lugui Qiu, Shuhua Yi
Journal: Blood
Blood (2025) 146 (Supplement 1): 5379.
https://doi.org/10.1182/blood-2025-5379
Published: 2025
Journal Articles

Combining axicabtagene ciloleucel (axi-cel) or relmacabtagene autoleucel (relma-cel) with HDT/ASCT in relapsed/refractory large B-cell lymphoma: A single-center experience

Free
Wei LIU, Yan Xu, Yi Wang, Weiwei Sui, Wenyang Huang, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 3720.
https://doi.org/10.1182/blood-2025-3720
Published: 2025
Journal Articles

Equecabtagene autoleucel in patients with relapsed or refractory multiple myeloma: The first real-world data from a single Chinese center

Free
Ruike Yan, Chun Gan, Ning Dai, Shuhui Deng, Wenjie Xiong, Shuaishuai Zhang, Wei LIU, Huimin Liu, Yi Wang, Rui Lv, Chenxing Du, Hesong Zou, Qi Wang, Wenyang Huang, Tingyu Wang, Weiwei Sui, Yuting Yan, Ying Yu, Mingwei FU, Liang Huang, Dehui Zou, Shuhua Yi, Lugui Qiu, Yan Xu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 4074.
https://doi.org/10.1182/blood-2025-4074
Published: 2025
Journal Articles

SOUNDTRACK-F1: A phase 3, randomized, open-label study of surovatamig (AZD0486) plus rituximab versus chemotherapy plus rituximab in patients with previously untreated follicular lymphoma

Free
Chan Cheah, Monique Menzies Wojtowicz, Dok Hyun Yoon, Dehui Zou, Rebecca Auer, Won-Seog Kim, Bor-Sheng Ko, Hung-Lin Liu, Lorenzo Falchi, Yuqin Song, Pier Luigi Zinzani, Daisuke Ennishi, Francesc Garcia Pallarols, Xiaofei Chen, Stefanie Meyer, Ricardo Espinola, Mihail Obrocea, Franck Morschhauser, Dai Maruyama, Tae Min Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 3614.
https://doi.org/10.1182/blood-2025-3614
Published: 2025
Journal Articles

Promising safety and efficacy of equecabtagene autoleucel (eque-cel) followed ASCT in ultra high-risk multiple Myeloma (UHR-MM) patients: primary real world data from a single center

Free
Ruike Yan, Chun Gan, Ning Dai, Shuhui Deng, Xiong Wenjie, Shuaishuai Zhang, Wei LIU, Huimin Liu, Yi Wang, Rui Lv, Chenxing Du, Hesong Zou, Qi Wang, Wenyang Huang, Tingyu Wang, Weiwei Sui, Yuting Yan, Ying Yu, Mingwei FU, Liang Huang, Dehui Zou, Shuhua Yi, Lugui Qiu, Gang An, Yan Xu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2299.
https://doi.org/10.1182/blood-2025-2299
Published: 2025
Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Free
Donglu Zhao, Huiqiang Huang, Zhiming Li, Lihong Liu, Quande Lin, Jun Fang, Kaiyang Ding, Jie Jin, Yanhong Tong, Dengju Li, Zengjun Li, Liping Su, Liang Wang, Wenbin Qian, Xiuhua Sun, Xiaobo Wang, Pengcheng He, Wei Yang, Jinhai Ren, Liling Zhang, Zunmin Zhu, Lugui Qiu, Dehui Zou, Wei LIU, Hui Zhou, Dongfeng Luo, Xiaojing Yan, Zhenqian Huang, Lintao Bi, Rong FU, Yunhong Huang, Aichun Liu, Xi Zhang, Yao Liu, Hao Zhang, Guangxun Gao, Liangquan Geng, Jingbo Wang, Jia Li, Yi Wang, Liqun Zou, Ming Jiang, Jian Ge, Xiu Li Sun, Yanli Yang, Hongmei Jing, Kai Hu, Zhimin Yan, Shuangnian Xu, Xiangxiang Zhou, Ganggang Wang, Zhilin Gao, Li Liang, Hongfeng Ge, Qingshan Li, Zhixue Zhang, Wuping Li, Xiaojing Xing, Fengzi Wang, Dongping Huang, Jun Qian, Hua Fan, Chanjuan Shen, Jun Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 1878.
https://doi.org/10.1182/blood-2025-1878
Published: 2025
Journal Articles

Chidamide in combination with azacitidine, mitoxantrone liposomes, and prednisone (CAMP regimen) for treatment-naïve TFH-derived peripheral T-cell lymphoma

Free
Huimin Liu, Wei LIU, Wenyang Huang, Yi Wang, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 1864.
https://doi.org/10.1182/blood-2025-1864
Published: 2025
Journal Articles

Clinical characteristics and prognostic analysis of 52 cases of ALK-positive anaplastic large cell lymphoma

Free
Wen Zhang, Wei LIU, Ting Xie, Tingyu Wang, Xiong Wenjie, Hesong Zou, Yi Wang, Shuhua Yi, Wenyang Huang, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 7165.
https://doi.org/10.1182/blood-2025-7165
Published: 2025
Journal Articles

Bispecific antibodies serve as a safe and effective bridging therapy prior to CD19 CAR T-cell therapy/combinational therapy of CD19 CAR-T cell and HDT/ASCT in patients with R/R DLBCL

Free
Yi Wang, Wei LIU, Huimin Liu, Qi Wang, Weiwei Sui, Rui Lv, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2025) 146 (Supplement 1): 4545.
https://doi.org/10.1182/blood-2025-4545
Published: 2025
Journal Articles

Serum free light chain escape before IMWG progression: A predictive marker and a therapeutic opportunity

Free
Chun Gan, Ning Dai, Ruike Yan, Shuhui Deng, Xiong Wenjie, Shuaishuai Zhang, Wei LIU, Huimin Liu, Yi Wang, Rui Lv, Chenxing Du, Hesong Zou, Qi Wang, Wenyang Huang, Tingyu Wang, Yuting Yan, Weiwei Sui, Ying Yu, Mingwei FU, Liang Huang, Dehui Zou, Shuhua Yi, Gang An, Lugui Qiu, Yan Xu
Journal: Blood
Blood (2025) 146 (Supplement 1): 4015.
https://doi.org/10.1182/blood-2025-4015
Published: 2025
Journal Articles

Zanubrutinib Plus Ixazomib & Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia:a Phase II Studyshort Title: Zid for Waldenström Macroglobulinemia

Free
Xiong Wenjie, Yuting Yan, Tingyu Wang, Weiwei Sui, Ying Yu, Tengteng Yu, Rui Lyu, Wei Liu, Huimin Liu, Gang An, Wenyang Huang, Dehui Zou, Lu-Gui Qiu, Shuhua Yi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2024-198864
Published: 2024
Journal Articles

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

Free
Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4761.
https://doi.org/10.1182/blood-2024-204355
Published: 2024
Journal Articles

CAC-MM-001: A B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Followed By Autologous Stem Cell Transplantation and Second CAR-T (CART-ASCT-CART2) in Newly Diagnosed Multiple Myeloma Patients with P53 Gene Abnormalities

Free
Yuntong Liu, Weiwei Sui, Rui Lyu, Chenxing DU, Shuaishuai Zhang, Tengteng Yu, Jingyu Xu, Wenqiang Yan, Yuting Yan, Wei Liu, Yi Wang, Qi Wang, Yan Xu, Shuhua Yi, Dehui Zou, Lu-Gui Qiu, Gang An
Journal: Blood
Blood (2024) 144 (Supplement 1): 3386.
https://doi.org/10.1182/blood-2024-200117
Published: 2024